In this study, the interference of T-DNA insertion upon Agrobacterium-mediated transformation on the biochemical expression of the host genome is discussed. Plant extracts of transgenic Artemisia annua L. with or without an overexpressed farnesyl pyrophosphate synthase gene have been investigated for their bioactivity and metabolic profile in comparison with wild type A. annua. The highest antimicrobial activity against Staphylococcus aureus, Bacillus subtilis and Candida albicans was observed in the T253 transgenic lines. Moreover, the crude extract from T253 showed higher antimalarial activity against the Plasmodium faciparum K1 strain than those of the others. The terpenoid constituents and antimicrobial properties of the plant samples were grouped by hierarchical clustering analysis. The clustering showed that squalene is a putative compound that might be involved in increasing the bioactivity of the transgenic line. In addition, T253 had a triterpene content that was about twice as great as that of the T253-2 line, which had a higher content of sesquiterpenes. However, both lines were transformed by the same FPS gene. These results suggested that the different bioactive properties observed in each transgenic line may be caused by variations in their terpenoid composition, which is affected by T-DNA insertion at different positions in the host plant.
Terpenoids are the largest group of natural products consisting of more than 40,000 compounds. Most of the high value compounds used as flavoring, fragrance and drugs are terpenoid compounds, which are commonly isolated from plants. Among these, artemisinin, a sesquiterpene lactone endoperoxide extracted from A. annua leaves, has shown antimalarial activity against the drug-resistant parasite Plasmodium falciparum. Artemisinin contents vary greatly from 0.01% to 0.8% of leaf dry weight [1a] , depending on the genetic background and cultivation conditions [1b,2a] . Besides artemisinin, A. annua produces several other secondary metabolites. Importantly, the essential oil extracted from A. annua showed antibacterial, antifungal and antioxidant activity [2b] . Various studies have focused on using genetic modification to manipulate the biosynthetic pathways of terpenoids. One of the key enzymes in terpenoid biosynthesis is farnesyl pyrophosphate synthase (FPS), which regulates the production of farnesyl pyrophosphate (FPP). Overexpression of FPS in A. annua had an effect on the artemisinin content [3,4a] , plant morphology and on the response of the transgenic lines to gibberellic acid (GA3) [4b] . Plant transformation techniques may affect the expression of the host genes near the insertion site [5a,b] . The effects of transformation on the bioactivity of A. annua transgenic lines and its alteration in production of the compounds in these plants have yet to be studied. We sought to determine the correlation between the bioactivity of plant extracts and their metabolic compositions using metabolic profiling techniques to achieve a more comprehensive characterization of the total metabolome.
The crude extract from the pooled leaves of each plant line (wt, T74, T711, T721, T253, T253-2 and T3/3C) of A. annua were tested against four microbial strains, Escherichia coli, Staphylococcus aureus, Bacillus subtilis and Candida albicans (Table1). No activity in all the tested crude extracts was observed against the Gramnegative bacterium, E. coli. The crude extract of the wild type (wt) showed no activity against B. subtilis, whereas it had a slight effect on S. aureus and C. albicans. Most of the transgenic lines were active against the Gram-positive bacteria (B. subtilis and S. aureus) and C. albicans to different degrees, with the exception of the T3/3C line, which had no bioactivity towards B. subtilis. Among the transgenic lines, T253 crudes had the highest activity against both B. subtilis and S. aureus. The highest inhibitory zones of 7.3 ± 0.8 mm and 9.3 ± 0.2 mm were detected using T253 crudes when tested against B. subtilis and S. aureus, respectively. The crude extracts of all tested A. annua lines had inhibitory effects towards Gram-positive bacteria, but not Gram-negative bacteria, most likely due to the lipopolysaccharides present in the outer membrane of the Gramnegative bacteria causing them to be more virulent and more resistant than Gram-positive bacteria [6] . Similar results from previous studies on the antimicrobial activity of Artemisia species extracted with either methanol or ethanol also demonstrated either moderate or no effect on Gram-negative bacteria [7a,b] . The crude extracts from all the plant lines could not inhibit the growth of C. albicans. Nevertheless, when 0.125 µg mL -1 ketoconazole (KTZ) was added into the culture media prior to addition of the crudes, growth inhibition was observed ( Table 1 ). The highest antifungal activity was detected in the crudes of the transgenic line T253 (24.5 ± 1.9 mm). This has significant implications as it has been reported that high concentrations of KTZ (≥40 µg mL -1 ) can cause overt disruption of the lymphocyte plasma membrane after exposure for 5 days in culture. Moreover, at 15-20 µg mL -1 , KTZ has been reported to decrease thymidine uptake and diminish blastogenesis of lymphocyte culture [8] . Therefore, this would provide an alternative treatment strategy which would allow the use of a low dose of KTZ in combination with A. annua extract in order to reduce the toxicity and side effects of KTZ on the human cell. The crude extracts that showed the highest antimicrobial activity against all three test microbes were from the transgenic T253 line. Although in our previous report [3] we demonstrated lower artemisinin content in the transgenic T253 than in T253-2, this present study showed greater bioactivity of T253 compared with T253-2 against Gram-positive bacteria and Candida. In order to identify the biochemical variations that may be affected by T-DNA insertion among the transgenic lines in comparison with their original wt plant, the constituents of the crude extracts of each line were examined (Table 2) . Comparisons with the metabolic profiles of wild type (wt) and transgenic lines T74, T711, T721, T3/3C, T253 and T253-2 were performed. The crude extract of each line was analyzed by GC-MS. The 26 major compounds in the crude extract that showed higher than 80% match-quality were then used for further analysis. The content percentages of each metabolite were normalized with methyl heptadecanoate. From the GC-MS analysis, most of the detected compounds were terpenoids, consisting of one monoterpene, nine sesquiterpenes, two diterpenes, and three triterpenes; eight other non-terpenoid compounds were also identified. The proportions of mono-, di-and tri-terpenoids were similar in wt (26.2% to 27.8%). However, in the six transgenic lines, the triterpenoid content was increased by 2-3 folds relative to wt. The highest triterpenoid proportion was observed in the T253 transgenic line (65.7%). The MeOH crude extracts of all the transgenic lines showed that the major percentage of the metabolites was terpenoids. Figure 1 shows the co-integrated data of the relative compound (%) contents of each identified metabolite (Table 2) with their antimicrobial properties (Table 1) shown for the different lines and further analyzed by hierarchical clustering analysis (HCA) using a Pearson correlation with MultiExperimental Viewer (MeV) software version 4.8.1. The HCA heat-map shows the correlation of both data sets. HCA confirmed that lines with the highest squalene contents were grouped in the same group as those with lines showing the highest antimicrobial activity. The transgenic line T253 showed the greatest antimicrobial activity. Interestingly, T253 and T253-2 were actually obtained from the same batch of transformations with a FPS-over expressing plasmid [3] . Through the selection process of putative transformants, the T253 and T253-2 lines were distinguished according to the different cell clump-derived plantlets. These variations in morphology have been reported previously for differences in artemisinin content [3] . This study further demonstrated the differences in these transgenic lines in terms of their antimicrobial activities and the variations in their terpenoid compounds. When the total ion chromatograms of the crude extracts of T253 and T253-2 were compared, we found three distinguished ions which were identified as triterpenoids (squalene, olean-12-ene and 3-keto-urs-12-ene) and which were dominantly present in the T253 line compared with the T253-2 line. This might be due to the different insertion positions of the T-DNA harboring the FPS gene in the A. annua genomes of both lines, which has been demonstrated by Banyai et al. [3] . The different insertional positions of the FPS transgene into the A. annua genome affected its ability to produce artemisinin as well as its phenotypic responses to an exogenous stimulus [3,4b] . It also resulted in metabolic changes in the biochemical contents, as shown in Table 2 and Figure   1 . In addition, the half maximal inhibitory concentration (IC 50 ) of the antimalarial activity of the transgenic lines T253 and T253-2 were measured in comparison to wt. The results showed antimalarial activity in the crude extracts of each of these three plant lines, with IC 50 values for T253, T253-2, and wt of 0.20, 0.33 and 0.23 µg mL -1 , respectively compared with dihydroartemisinin (0.78 x 10 -3 µg mL -1 ) and mefloquine (0.012 µg mL -1 ), the positive controls. Therefore, the transgenic T253 line has a lower IC 50 and thus higher antimalarial activity than T253-2 and the wild type. This might be attributable to the amount of squalene in T253, which was 8 times greater than in T253-2 and 50 times greater than in wt, and may promote a synergistic effect with artemisinin derivatives against malarial parasites. Previous studies have reported that squalene shows anti-cancer, anti-oxidant, anti-tumor, chemopreventive, and pesticidal properties, as well as playing an important role in protection against sunburn [9, 10] . Moreover, squalene has been reported for its antimalarial activity with an IC 50 ranging from 25-50 µg mL -1 [11] . Although our previous study reported on the higher artemisinin content of in vitro culture of transgenic T253-2 (1.3 %, DW), which was about 1.4 and 2.7 times higher than that of T253 and wt [3] , the antimalarial activity of T253 was 1.2-1.6 times higher that wt and T253-2. Therefore, this may be caused by the effect of squalene that accumulated in T253.
This report demonstrates that different insertions of the transgene not only altered the biochemical profiles but also had an effect on the bioactivity, as shown in Table 1 . The FPS gene regulates the production of FPP (farnesyl pyrophasphate), which is one of the important intermediate compounds in the metabolic pathway of terpenoid biosynthesis that is used in sesquiterpene and triterpene production [12,13a,b] . Interestingly, the transgenic line T253-2 had 26.8% sesquiterpenes, which was about 2 fold higher than that in line T253 (12.0%). In contrast, the triterpenoids content of T253-2 was 30.4%, which was 2 times lower than in line T253 (65.7%). These differences in proportions between sesquiterpenes and triterpenes in the FPS-overexpressing transgenic line T253-2 and T253 showed negative correlation equal to -0.824 when analyzed by the Pearson product-moment correlation analysis with p ≤ 0.05. Therefore, we show in this present study that overexpression of the FPS gene at different positions interfered with the metabolic flux of both terpenoid compounds and resulted in the different relative production of C15 and C30 terpenoids. T-DNA insertion also had an effect on the metabolic profiles of A. annua, even in transgenic lines derived from standard recombinant plasmid of pCAMBIA1301 without the FPS gene (line T74, T711, T721 and T3/3C).
The differences in the proportions of terpenoid types and content in each transgenic line will enable us to better understand the role of gene expression in the metabolic pathway and allow us to further implement this knowledge to improve the production of these important compounds for pharmaceutical use.
Experimental

Plant material and crude extraction: Vietnam seeds of A. annua
were surface-sterilized and cultured in 0.7% semi-solid MS medium with 3% (w/v) sucrose, at 25 ± 2°C, 60 ± 5%RH and 16 h photoperiod with 60 ± 5 μmol m −2 s −1 PPF. The selected seed-germinated A. annua (wide type, wt) were proliferated on the same medium. The leaflets from in vitro cultures of wt were transformed by A. tumefaciens strain EHA105 containing recombinant plasmid pCAMBIA1301 (CAMBIA, Australia) and recombinant plasmid containing FPS gene named pCAMBIAFPS (GenBank: GQ420346) by vacuum treatment [3] . The transgenic lines were tested and confirmed by histochemical analysis of -glucuronidase (GUS) activity and Southern blot hybridization of transgenic plants
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obtained pCAMBIA1301 (T74, T711, T721, T3/3C) and pCAMBIAFPS (T253, T253-2). Acclimatization and transplantation was according to the method described by Banyai et al. [13c] . Leaves taken from 45-day-old transplants (4 replicates per line) were dried at 50°C in a hot air oven and stored at −80°C until use. Five g dry weight (DW) of pooled A. annua leaves were extracted with 50 mL methanol (MeOH), and the extract was evaporated in a rotary evaporator and stored at -20°C until used.
Determination of antimicrobial activity:
The antimicrobial activities of crude extracts were determined by the disc diffusion method. The tested microorganisms consisted of 2 Gram-positive bacteria (S. aureus ATCC 25923 and B. subtilis ATCC 6633), one Gram-negative bacterium (E. coli ATCC 25922), and one yeast (C. albicans ATCC 90028). Each bacterial strain suspension was prepared and diluted in Mueller-Hinton broth to 10 6 CFU mL -1 . Suspensions of S. aureus, B. subtillisor E. coli were mixed with Mueller-Hinton agar (Difco, BD, Sparks, MD) at 1% inoculums, and then were each poured into Petri dishes. The C. albicans suspension was added into Sabouraud dextrose agar (SDA) with or without the addition of a sub-inhibitory concentration of ketoconazole at 0.125 mg mL -1 [14] . A total of 9 mL of the medium seeded with C. albicans was pipette into a plastic Petri dish. Each of the crude samples was dissolved at 10 µg µL -1 in dimethylsulfoxide (DMSO) and applied (10 µL each) to a paper discthat was placed on the surface of inoculated agar. The same volume of pure DMSO was used as a control. After being kept at room temperature for 1 h, the test plates were incubated at 37°C for 24 h. The inhibitory zones were then measured.
Determination of antimalarial activity:
Fifty mg (DW) of 30 dayold leaves of in vitro grown plants were extracted with 1 mL MeOH. The extracts were tested for their antimalarial activity against Plasmodium falciparum (K1, multi-drug resistant strain)
according to the method of Trager and Jensen [15a] . Quantitative determination of in vitro antimalarial activity was made by microculture radioisotope techniques based on the methods described by Desjardins et al.
[15b] using dihydroartemisinin (DHA) and mefloquine as positive controls. Levels of incorporated radioactively labeled hypoxanthine, which indicated parasite growth, were determined using a TopCount microplate scintillation counter (Packard, USA).
Gas chromatography mass spectrometry (GC-MS) analysis:
The biochemical profiles of the crude extracts were analyzed using GC-MS (HP-6890) with a HP5-ms capillary fused silica column (30 m, 0.25 mm I.D.; 0.25 m film thickness). The oven temperature program was initiated at 40 °C then raised at 4 °C/min to 300 °C. After that, the temperature was increased at a rate of 5 °C/min to 320 °C and held for 10 min. Other operating conditions were as follows: carrier gas, He (99.999%); with a flow rate of 1 mL min -1 , injector temperature, 250 °C; splitless. Mass spectra were taken at 70 eV. Mass range was from m/z 30-500 amu. Raw data were processed with Hystar 3.1 (Agilent  ). The compound names were searched for in the Wiley 7 No.1 Library, and only the compounds that had 80% match-quality were considered and used for further analysis.
Clustering analysis of the plant metabolic profiles for samples with bioactivity:
Clustering of the large-scale phytochemical analysis of plant metabolites with observed bioactivity was performed as previously described using the grouping technique [15c]. The MultiExperiment Viewer (MeV) version 4.8.1 was used for analysis, visualization and data-mining of the large-scale data set [15d]. The grouping results as shown in the dendrogram with a heat-map showed the individual values of the relative contents of each compound in a matrix in different colors. The degrees of differences between the structures are indicated by the relative branch lengths.
